HSCSW · Insider Trading

HeartSciences Inc. Warrant

Every open-market purchase and sale reported by HSCSW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
26
most recent
Open-Market Buys
0
code P
Sales
1
code S
Reporting Insiders
2
current holders
HSCSW — Recent Form 4 Transactions (latest 2026-01-12)
FiledInsiderRole TypeSharesValue
2026-01-12 Bruce Bent Director A +15,000 deriv. —
2026-01-12 David R. Wells Director A +15,000 deriv. —
2025-12-22 Brian Szymczak Director A +15,000 deriv. —
2025-12-22 Danielle Watson See Remarks A +15,000 deriv. —
2025-12-22 Mark T Hilz See Remarks A +45,000 deriv. —
2025-11-28 Andrew Simpson See Remarks A +70,000 —
2025-07-30 Mark T Hilz COO, Secretary and Director Sell −4,416 −$15.62K
2025-07-14 Bruce Bent Director A +25,000 deriv. —
2025-07-11 David R. Wells Director A +25,000 deriv. —
2025-07-11 Danielle Watson See Remarks A +25,000 deriv. —
2025-07-11 Brian Szymczak Director A +25,000 deriv. —
2025-07-11 Mark T Hilz See Remarks A +281,250 deriv. —
2025-07-11 Andrew Simpson See Remarks A +343,750 deriv. —
2025-01-23 Bruce Bent Director A +6,000 deriv. —
2025-01-21 Brian Szymczak Director A +6,000 deriv. —
2025-01-21 David R. Wells Director A +6,000 deriv. —
2025-01-21 Danielle Watson See Remarks A +9,000 deriv. —
2025-01-21 Andrew Simpson See Remarks A +45,000 deriv. —
2025-01-21 Mark T Hilz See Remarks A +45,000 deriv. —
2024-08-14 Andrew Simpson See Remarks J +17 —
2023-03-22 Danielle Watson See Remarks A +75,000 deriv. —
2023-03-22 Mark T Hilz See Remarks A +300,000 deriv. —
2023-03-22 Brian Szymczak Director A +50,000 deriv. —
2023-03-22 David R. Wells Director A +50,000 deriv. —
2023-03-22 Andrew Simpson See Remarks A +300,000 deriv. —
2023-03-22 Bruce Bent Director A +50,000 deriv. —
HSCSW — Current Insider Holders
InsiderRole Shares HeldValue
Andrew Simpson See Remarks 74,382 $4.54K
Mark T Hilz See Remarks 4,793 $292
HSCSW Insider Trading FAQ
Who are the insiders at HSCSW?
2 officers, directors and 10%+ beneficial owners currently report holdings in HSCSW via SEC Form 4.
Are HSCSW insiders buying or selling?
Across the 26 most recent Form 4 filings for HSCSW, 0 were open-market purchases (code P) and 1 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is HSCSW insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent HSCSW filing is dated 2026-01-12.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the HSCSW quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.